['type 2 diabetes']
['hm11260c', 'liraglutide', 'placebo']

        Inclusion Criteria:

          -  Ages eligible for study : 18 years to 74 years

          -  Genders eligible for study : Male and Female

          -  Diagnosed with T2DM

          -  Received diet and exercise therapy with or without metformin monotherapy

          -  HbA1c levels of between ≥ 7.0% and ≤ 10.0%

          -  Females of childbearing potential who are not pregnant and agree to use a reliable
             method of birth control

          -  Written informed consent must be obtained

        Exclusion Criteria:

          -  Pregnant or nursing (lactating) women

          -  Diagnosis of type 1 diabetes mellitus

          -  Uncontrolled diabetes defined as a FPG level of > 240 mg/dL

          -  A significant change in body weight in the 3 months before screening

          -  Any history of GI intolerance

          -  Personal or family history of medullary thyroid cancer (MTC) or a genetic condition
             that predisposes to MTC

          -  Known history of chronic pancreatitis

          -  A history of alcohol or drug abuse or drug addiction
      